1,170 results on '"Swisher, Stephen"'
Search Results
2. Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival
3. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non–small cell lung cancer: Evidence for surgery in advanced disease
4. Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer
5. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
6. Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy
7. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma
8. Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery
9. Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
10. Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy
11. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals
12. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
13. Removing Implicit Bias From Cardiothoracic Surgery Resident Recruitment: Changing the Paradigm
14. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial
15. Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection
16. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
17. Financial Toxicity in Patients With Resected Lung Cancer
18. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non–Small Cell Lung Cancer
19. Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
20. Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
21. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment
22. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
23. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
24. Synchronous Esophageal and Lung Cancers—Is Combined Anatomic Resection Appropriate?
25. Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
26. Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection
27. Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model
28. Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity
29. Is the Centralization of Complex Surgical Procedures an Unintended Spillover Effect of Global Capitation? – Insights from the Maryland Global Budget Revenue Program
30. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed
31. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
32. Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
33. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy
34. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival
35. Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
36. Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target
37. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC
38. Role of neoadjuvant chemoimmunotherapy for resectable NSCLC
39. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
40. Octreotide's role in the management of post-esophagectomy chylothorax.
41. Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
42. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non–Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients
43. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
44. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
45. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding
46. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non–Small-Cell Lung Cancer
47. Estimated Financial Impact of 2021 Office-Visit Work Relative Unit Updates on Surgical Global Periods.
48. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
49. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
50. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.